A study of human leukocyte antigen‐haploidentical hematopoietic stem cells transplantation combined with allogenic mesenchymal stem cell infusion for treatment of severe aplastic anemia in pediatric and adolescent patients

A study of human leukocyte antigen‐haploidentical hematopoietic stem cells transplantation combined with allogenic mesenchymal stem cell infusion for treatment of severe aplastic anemia in pediatric and adolescent patients

Abstract The clinical applications of human leukocyte antigen (HLA) haploidentical hematopoietic stem cells transplantation (haplo‐HSCT) have offered most of the young severe aplastic anemia (SAA) patients an opportunity to accept curative therapy at the early stage of bone marrow lesions. However,...

Full description

Bibliographic Details
Main Authors: Li Ding, Dong‐Mei Han, Xiao‐Li Zheng, Hong‐Min Yan, Mei Xue, Jing Liu, Ling Zhu, Sheng Li, Ning Mao, Zi‐Kuan Guo, Hong‐Mei Ning, Heng‐Xiang Wang, Heng Zhu
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:Stem Cells Translational Medicine
Subjects:
bone marrow niche
graft vs host disease
HLA‐haploidentical HSCT
mesenchymal stem cells
pediatric and adolescent patients
severe aplastic anemia
Online Access:https://doi.org/10.1002/sctm.20-0345

Internet

https://doi.org/10.1002/sctm.20-0345

Similar Items